Bartlett & Co Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bartlett & Co Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$494K	Hold	3,120	–	–	0.01%	353
2026 Q1	$417K	Hold	3,120	–	–	0.01%	363
2025 Q4	$380K	Hold	3,120	–	–	0.01%	366
2025 Q3	$313K	Hold	3,120	–	–	﹤0.01%	397
2025 Q2	$259K	Hold	3,120	–	–	﹤0.01%	411
2025 Q1	$253K	Hold	3,120	–	–	﹤0.01%	421
2024 Q4	$281K	Hold	3,120	–	–	﹤0.01%	399
2024 Q3	$308K	Hold	3,120	–	–	﹤0.01%	393
2024 Q2	$289K	Hold	3,120	–	–	﹤0.01%	401
2024 Q1	$296K	Hold	3,120	–	–	﹤0.01%	404
2023 Q4	$283K	Hold	3,120	–	–	﹤0.01%	426
2023 Q3	$228K	Sell	3,120 -375	-11%	-$30K	﹤0.01%	431
2023 Q2	$291K	Hold	3,495	–	–	0.01%	408
2023 Q1	$266K	Sell	3,495 -450	-11%	-$37.3K	0.01%	350
2022 Q4	$327K	Hold	3,945	–	–	0.01%	330
2022 Q3	$313K	Hold	3,945	–	–	0.01%	319
2022 Q2	$293K	Hold	3,945	–	–	0.01%	330
2022 Q1	$355K	Hold	3,945	–	–	0.01%	330
2021 Q4	$442K	Hold	3,945	–	–	0.01%	308
2021 Q3	$496K	Hold	3,945	–	–	0.01%	258
2021 Q2	$534K	Hold	3,945	–	–	0.01%	253
2021 Q1	$535K	Hold	3,945	–	–	0.01%	256
2020 Q4	$555K	Hold	3,945	–	–	0.01%	244
2020 Q3	$440K	Sell	3,945 -300	-7%	-$33.6K	0.01%	252
2020 Q2	$475K	Hold	4,245	–	–	0.01%	239
2020 Q1	$329K	Hold	4,245	–	–	0.01%	258
2019 Q4	$404K	Hold	4,245	–	–	0.01%	276
2019 Q3	$324K	Hold	4,245	–	–	0.01%	286
2019 Q2	$372K	Hold	4,245	–	–	0.01%	219
2019 Q1	$384K	Hold	4,245	–	–	0.01%	215
2018 Q4	$305K	Hold	4,245	–	–	0.01%	226
2018 Q3	$407K	Hold	4,245	–	–	0.02%	213
2018 Q2	$404K	Hold	4,245	–	–	0.02%	213
2018 Q1	$372K	Buy	+4,245	New	+$388K	0.02%	211

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Bartlett & Co Wealth Management's XBI Position: Q2 2026 in Review

Bartlett & Co Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,120 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #353.

Bartlett & Co Wealth Management first reported a position in XBI in Q1 2018 and has held it in 34 quarters since. The position peaked at $555K in Q4 2020. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bartlett & Co Wealth Management held 3,120 shares of State Street SPDR S&P Biotech ETF worth $494K as of Q2 2026.
Bartlett & Co Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #353 holding.
Bartlett & Co Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 34 quarters since.
Bartlett & Co Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $555K in Q4 2020.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.